SynthesisCancer reports (Hoboken, N.J.)2023

Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-response meta-analysis.

Matin Ghanavati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.